Hypotriglyceridemic effect of Anka (a fermented rice product of Monascus sp.) in rats

Journal of Agricultural and Food Chemistry

Volumn 48, Issue 8, 2000, Pages 3183-3189

  Wang, I K ^a   Lin Shiau, S Y ^a   Chen, P C ^a   Lin, J K ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Anka; Cholesterol; HD L C; Hepatic lipase; Hypertriglyceridemia; LDL C; Lipoprotein lipase; Monascus sp.; SOD; Triglyceride; VLDL C

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ANTILIPEMIC AGENT; CHOLESTEROL; FRUCTOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; MONACOLIN L; PLANT EXTRACT; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DIETARY INTAKE; FERMENTATION; FRUCTOSE METABOLISM; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; ISOLATION AND PURIFICATION; MALE; METABOLISM; NONHUMAN; RAT; RAT STRAIN; RICE; RISK FACTOR;

ANIMALS; ANTILIPEMIC AGENTS; CHOLESTEROL; FERMENTATION; HYPERTRIGLYCERIDEMIA; MALE; ORYZA SATIVA; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

ANIMALIA; MONASCUS;

EID: 0033851268     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf9909353     Document Type: Article

References (29)

1. Hypercholesteremia with predisposition to atherosclerosis: An inborn error of lipid metabolism
2. Serum lipids, hypertension, and coronary artery disease
3. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond
4. Assay of lipoprotein lipase and hepatic lipase
5. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high-density lipoprotein-cholesterol levels with or without hypertriglyceridemia
6. Serum triglyceritles in health and in ischaemic heart disease
7. Is the level of serum triglyceride a significant predictor of coronary death in 'normocholesterolemic' subjects? The Paris prospective study
8. Single risk factor intervention may he inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist
9. Compactin (MG236B) and related compounds as potential cholesterol lowering agents that inhibit HMG-CoA reductase
10. A new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase
11. A new hypocholesterolemic agent produced by a Monascus species
12. Dihydromonacolin L and monacolln Y new metabolites those inhibit cholesterol biosynthesis
13. Monacolins J and L, new inhibitors of cholesterol biosynthesis produced by Monascus tuber
14. Monacolin M. A new inhibitor of cholesterol biospthesis
15. Detection of individual susceptibility toward coronary disease
16. A simple method for the isolation and purification of total lipids from animal tissues
17. Predicting coronary heart disease in middle-aged and older persons: The Framingham Study
18. High-density lipoprotein as a protective factor against coronary heart disease
19. The actions of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose-fed rats
20. Role of dietary flavonoids in protection against cancer and coronary heart disease
21. Serum cholesterol, lipoproteins, and the risk of coronary heart disease
22. Cholesterol in the prediction of atherosclerotic disease
23. Composition of human low-density lipoprotein: Effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein
24. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial
25. Triglyceride lipases and atherosclerosis
26. Oxidized low-density lipoproteins in atherogenesis: Role of dietary modification
27. Antioxidant effects of lovastatin and vitamin E on experimental atherosclerosis in rabbits
28. Low-density lipoprotein oxidation and its pathobiological significance
29. Effects of mepanipyrim on lipid metabolism in rats